Industry ยท Oct 2026
Medical Instruments & Supplies stocks ranked by gap to the model's fair value
Faircurve's model values 18 medical instruments & supplies stocks. 13 of them are ranked below by the gap between the model's fair value and the last close, as of 31 Oct 2026: 1 read as Undervalued, 10 as Fairly valued and 2 as Overvalued. The median gap across the ranked names is -4.9%. The widest gaps above the price are ICUI (+19.7%), RMD (+14.2%), COO (+11.8%). The widest below it are RGEN (-19.8%), ISRG (-19.5%), LMAT (-9.8%).
Valuations as of . Prices are the closes of 3 Nov 2026. The gap is the model's fair value against the price: a positive gap means the fair value is above the price. It states what the model concluded, not where the price goes next.
The ranking
| Rank | Company | Last close | Model fair value | Gap | Model verdict | Quality score | Market value |
|---|---|---|---|---|---|---|---|
| 1 | ICUI ICU Medical, Inc. | $161.83 | $193.63 | +19.7% | Undervalued | 49 | $4.1B |
| 2 | RMD ResMed Inc. | $227.08 | $259.22 | +14.2% | Fairly valued | 77 | $32.3B |
| 3 | COO The Cooper Companies, Inc. | $60.83 | $68.01 | +11.8% | Fairly valued | 55 | $11.3B |
| 4 | BDX Becton, Dickinson and Company | $198.17 | $194.07 | -2.1% | Fairly valued | 45 | $53.9B |
| 5 | MMSI Merit Medical Systems, Inc. | $84.16 | $81.34 | -3.4% | Fairly valued | 65 | $5.1B |
| 6 | STAA STAAR Surgical Company | $25.17 | $23.97 | -4.8% | Fairly valued | 55 | $1.2B |
| 7 | SOLV Solventum Corporation | $84.76 | $80.57 | -4.9% | Fairly valued | 50 | $13.8B |
| 8 | WST West Pharmaceutical Services, Inc. | $406.99 | $383.18 | -5.9% | Fairly valued | 58 | $29.0B |
| 9 | ATR AptarGroup, Inc. | $142.31 | $132.22 | -7.1% | Fairly valued | 57 | $8.7B |
| 10 | BAX Baxter International Inc. | $25.49 | $23.62 | -7.3% | Fairly valued | 32 | $11.9B |
| 11 | LMAT LeMaitre Vascular, Inc. | $80.60 | $72.73 | -9.8% | Fairly valued | 69 | $1.9B |
| 12 | ISRG Intuitive Surgical, Inc. | $440.75 | $354.62 | -19.5% | Overvalued | 70 | $152.6B |
| 13 | RGEN Repligen Corporation | $178.27 | $142.95 | -19.8% | Overvalued | 60 | $11.2B |
The Global Pulse
Faircurve's market note, in your inbox each market day
The Global Pulse is Faircurve's note after each US session: what moved, in plain words. No account needed.
Valued but not ranked
These 5 names are valued but not ranked, for one of four reasons: the model grades the evidence as low or has not graded it yet, the inputs are under review, the gap is wider than 60%, or the valuation is more than three weeks old. The numbers are shown for reference.
| Company | Last close | Model fair value | Gap | Why it is not ranked | Quality score | Market value |
|---|---|---|---|---|---|---|
| AVTR Avantor, Inc. | $15.59 | $19.12 | +22.6% | Low evidence grade | 51 | $10.9B |
| EMBC Embecta Corp. | $6.08 | $4.45 | -26.8% | Low evidence grade | 65 | $354M |
| NVST Envista Holdings Corp | $24.77 | $27.44 | +10.8% | Low evidence grade | 61 | $3.8B |
| TFX Teleflex Incorporated | $139.95 | $142.86 | +2.1% | Low evidence grade | 59 | $5.9B |
| XRAY DENTSPLY SIRONA Inc. | $9.73 | $17.50 | +79.9% | Gap wider than 60% | 56 | $1.9B |